Mereo BioPharma (MREO) Research & Development (2023 - 2026)
Mereo BioPharma (MREO) posted Research & Development of $1.81 million for Q2 2026, down 66.4% from $5.37 million a year earlier and down 61.9% from the prior quarter.
Powered by 
Analysis
Mereo BioPharma (MREO) Research & Development (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Mereo BioPharma was $15.02 million, down 29.5% year-over-year; for FY2025, it was $17.77 million, down 15.1% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of -3.8% (FY2020 to FY2025).
- In prior years, Mereo BioPharma's Research & Development was $20.93 million in FY2024 (+20.2%), $17.42 million in FY2023 (-40.9%), $29.47 million in FY2022 (-7.2%) and $31.76 million in FY2021 (+47.1%).
- The Q2 2026 figure stands as the lowest quarterly Research & Development in data going back to Q1 2023.
- On a year-over-year basis, Research & Development increased in four of the last eight quarters, with growth averaging 1.9%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q4 2024, with growth of 83.6%; the weakest was Q2 2026, with a decline of 66.4%.
- According to Business Quant data, Research & Development for the three prior quarters was $4.75 million (Q1 2026), $4.19 million (Q4 2025) and $4.27 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Mereo BioPharma | 46.45 Mn | -103.46 Mn | - | 1.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.81 Mn |
| Mar 31, 2026 | 4.75 Mn |
| Dec 31, 2025 | 4.19 Mn |
| Sep 30, 2025 | 4.27 Mn |
| Jun 30, 2025 | 5.37 Mn |
| Mar 31, 2025 | 3.93 Mn |
| Dec 31, 2024 | 8.82 Mn |
| Sep 30, 2024 | 3.17 Mn |
| Jun 30, 2024 | 4.95 Mn |
| Mar 31, 2024 | 3.99 Mn |
| Dec 31, 2023 | 4.80 Mn |
| Sep 30, 2023 | 3.59 Mn |
| Jun 30, 2023 | 3.71 Mn |
| Mar 31, 2023 | 5.31 Mn |
API Access
Mereo BioPharma Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=MREO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "MREO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=MREO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();